Penn Medicine's 2020 Updates in Care of the Hematologic Malignancies Patient
Update on Patient Care Treatment Strategies in Leukemia
Penn Medicine's 2020 Updates in Care of the Hematologic Malignancies Patient
ASH 2019 Updates on MDS Treatment: Luspatercept Reduces Anemia, Lenalidomide and Epoetin Alfa Leads to Durable Responses, Experience with HMAs, ASTX727 as Alternative to IV Decitabine
FEATURING
Shannon McCurdy
- 83 views
- February 24, 2020